Fortress Biotech, Inc. (NASDAQ:FBIO) Held Back By Insufficient Growth Even After Shares Climb 31%

Simply Wall St10/26 21:33

Highbridge Capital Management's Strategic Acquisition of Fortress Biotech Shares

Yahoo Finance10/26 01:02

Mustang Bio Announces Exercise of Warrants for $4 Million Gross Proceeds

GlobeNewswire10/25 02:10

Airspan Completes Strategic Transition for Long-Term Success, Secures $85.4 Million in New Equity Financing

Businesswire10/12 00:36

Avenue Therapeutics to Participate in Maxim Group's 2024 Healthcare Virtual Summit

GlobeNewswire10/09 20:30

Fortress Biotech Files to Sell 6.19M Shares of Common Stock for Holders

Seeking Alpha09/28 05:00